Biotech · Private company
Acrotech Biopharma Inc.
Track this companyFree. Adds Acrotech Biopharma Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials253 recruiting or active
Pipeline programs36From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline36
- Belinostat InjectionPhase 3 · Peripheral T Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- CHOPPhase 3 · Peripheral T Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- COPPhase 3 · Peripheral T Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- DifamilastPhase 3 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- Pralatrexate InjectionPhase 3 · Peripheral T Cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Alkeran for Injection/Melphalan HCL for Injection (Propylene Glycol-Free)Phase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Autologous TransplantationPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Belinostat, Carboplatin, PaclitaxelPhase 2 · Stage IV Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 2 · Acute Lymphoblastic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Folic AcidPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Folic AcidPhase 2 · Relapsed or Refractory Lymphoproliferative MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- Folic AcidPhase 2 · Carcinoma, Transitional CellClinicalTrials.gov · fetched Nov 12, 2026
- Gemcitabine HydrochloridePhase 2 · Relapsed or Refractory Lymphoproliferative MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- High-Dose Melphalan HCL for Injection (Propylene Glycol-Free)Phase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Melphalan HCL for Injection (Propylene Glycol-Free)/Alkeran for InjectionPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- Pralatrexate InjectionPhase 2 · Carcinoma, Transitional CellClinicalTrials.gov · fetched Nov 12, 2026
- Pralatrexate InjectionPhase 2 · Relapsed or Refractory Lymphoproliferative MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- Pralatrexate InjectionPhase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Vincristine Sulfate Liposome Injection plus rituximabPhase 2 · Non-Hodgkin's LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Vincristine Sulfate Liposomes InjectionPhase 2 · Acute Lymphoblastic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Vitamin B12Phase 2 · Relapsed or Refractory Lymphoproliferative MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- Vitamin B12Phase 2 · Carcinoma, Transitional CellClinicalTrials.gov · fetched Nov 12, 2026
- Vitamin B12Phase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- AtazanavirPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BelinostatPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- BelinostatPhase 1 · Peripheral T-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Belinostat IVPhase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Bexarotene CapsulesPhase 1 · Cutaneous T-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Folic AcidPhase 1 · Cutaneous T-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- MarqiboPhase 1 · SarcomaClinicalTrials.gov · fetched Nov 12, 2026
- PralatrexatePhase 1 · Cutaneous T-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Pralatrexate InjectionPhase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Pralatrexate InjectionPhase 1 · Peripheral T-Cell Lymphoma (PTCL)ClinicalTrials.gov · fetched Nov 12, 2026
- Pralatrexate InjectionPhase 1 · Cutaneous T-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
- Vincristine Sulfate Liposomes InjectionPhase 1 · Malignant MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Vitamin B12Phase 1 · Cutaneous T-cell LymphomaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLPHASE3 · ACTIVE_NOT_RECRUITING · started Oct 4, 2023ClinicalTrials.gov NCT06072131 · fetched Nov 12, 2026
- Study to Evaluate the Pharmacokinetics and Safety of Pralatrexate in Patients With Advanced Solid Tumor or Hematological Malignancy and Either Normal Hepatic Function or Mild, Moderate, or Severe Hepatic ImpairmentPHASE1 · RECRUITING · started Dec 28, 2022ClinicalTrials.gov NCT07036133 · fetched Nov 12, 2026
- This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)PHASE3 · COMPLETED · started Oct 1, 2022ClinicalTrials.gov NCT05608343 · fetched Nov 12, 2026
- A Open-label Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic DermatitisPHASE3 · COMPLETED · started Sep 15, 2022ClinicalTrials.gov NCT05571943 · fetched Nov 12, 2026
- Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALLPHASE2 · WITHDRAWN · started Jan 1, 2022ClinicalTrials.gov NCT04448834 · fetched Nov 12, 2026
- Binimetinib Plus Belinostat for Subjects With Metastatic Uveal MelanomaPHASE2 · ACTIVE_NOT_RECRUITING · started Dec 15, 2021ClinicalTrials.gov NCT05170334 · fetched Nov 12, 2026
- Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian CancerPHASE1 · COMPLETED · started Mar 4, 2021ClinicalTrials.gov NCT04703920 · fetched Nov 12, 2026
- Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat TrialsPHASE1 · COMPLETED · started Aug 5, 2019ClinicalTrials.gov NCT04184869 · fetched Nov 12, 2026
- Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 GenotypesPHASE1 · COMPLETED · started Apr 27, 2016ClinicalTrials.gov NCT02680795 · fetched Nov 12, 2026
- A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)PHASE1 · COMPLETED · started Nov 10, 2015ClinicalTrials.gov NCT02594267 · fetched Nov 12, 2026
- Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)PHASE1 · COMPLETED · started May 1, 2013ClinicalTrials.gov NCT01839097 · fetched Nov 12, 2026
- Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous TransplantationPHASE2 · COMPLETED · started Dec 1, 2012ClinicalTrials.gov NCT01660633 · fetched Nov 12, 2026
- MTD Study PXD-101 in Combination With Paclitaxel + Carboplatin in Chemotherapy-Naive Patients With Stage IV NSCLCPHASE1_PHASE2 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01310244 · fetched Nov 12, 2026
- To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory CancerPHASE1 · COMPLETED · started Sep 1, 2010ClinicalTrials.gov NCT01222780 · fetched Nov 12, 2026
- Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaPHASE1 · COMPLETED · started Mar 1, 2010ClinicalTrials.gov NCT01134341 · fetched Nov 12, 2026
- Study of Pralatrexate in Female Patients With Previously-treated Breast CancerPHASE2 · COMPLETED · started Mar 1, 2010ClinicalTrials.gov NCT01118624 · fetched Nov 12, 2026
- Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment RegistryCOMPLETED · started Feb 1, 2010ClinicalTrials.gov NCT01110733 · fetched Nov 12, 2026
- PK Study of Melphalan HCL & Alkeran for Injection of MA Conditioning in MM Patients of Autologous TransplantationPHASE2 · COMPLETED · started Jan 1, 2010ClinicalTrials.gov NCT00925782 · fetched Nov 12, 2026
- Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary BladderPHASE2 · COMPLETED · started Jul 1, 2008ClinicalTrials.gov NCT00722553 · fetched Nov 12, 2026
- Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaPHASE1 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00554827 · fetched Nov 12, 2026
- Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative MalignanciesPHASE1_PHASE2 · COMPLETED · started May 1, 2007ClinicalTrials.gov NCT00481871 · fetched Nov 12, 2026
- Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell LymphomaPHASE2 · COMPLETED · started Aug 1, 2006ClinicalTrials.gov NCT00364923 · fetched Nov 12, 2026
- Pharmacokinetic Study of Liposomal Vincristine in Patients With Malignant Melanoma & Hepatic DysfunctionPHASE1 · COMPLETED · started Feb 1, 2005ClinicalTrials.gov NCT00145041 · fetched Nov 12, 2026
- Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaPHASE1_PHASE2 · COMPLETED · started Jul 1, 2002ClinicalTrials.gov NCT00144963 · fetched Nov 12, 2026
- Phase 1/2 Study of VSLI Plus Rituximab in Patients With Relapsed and/or Refractory NHLPHASE1_PHASE2 · COMPLETED · started Sep 1, 2001ClinicalTrials.gov NCT01851551 · fetched Nov 12, 2026